CGON logo

CG Oncology, Inc. (CGON) Shareholders equity

annual shareholders equity:

$733.38M+$548.59M(+296.87%)
December 31, 2024

Summary

  • As of today (August 26, 2025), CGON annual stockholders equity is $733.38 million, with the most recent change of +$548.59 million (+296.87%) on December 31, 2024.
  • During the last 3 years, CGON annual shareholders equity has risen by +$693.13 million (+1721.96%).
  • CGON annual shareholders equity is now at all-time high.

Performance

CGON Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONbalance sheet metrics

quarterly shareholders equity:

$670.36M-$34.40M(-4.88%)
June 30, 2025

Summary

  • As of today (August 26, 2025), CGON quarterly stockholders equity is $670.36 million, with the most recent change of -$34.40 million (-4.88%) on June 30, 2025.
  • Over the past year, CGON quarterly shareholders equity has increased by +$118.00 million (+21.36%).
  • CGON quarterly shareholders equity is now -8.59% below its all-time high of $733.38 million, reached on December 31, 2024.

Performance

CGON quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

CGON Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+296.9%+21.4%
3 y3 years+1722.0%+435.5%
5 y5 years+1722.0%+435.5%

CGON Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1722.0%-8.6%+435.5%
5 y5-yearat high+1722.0%-8.6%+435.5%
alltimeall timeat high+1722.0%-8.6%+435.5%

CGON Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$670.36M(-4.9%)
Mar 2025
-
$704.76M(-3.9%)
Dec 2024
$733.38M
$733.38M(+36.6%)
Sep 2024
-
$536.77M(-2.8%)
Jun 2024
-
$552.36M(-2.9%)
DateAnnualQuarterly
Mar 2024
-
$568.94M(+207.9%)
Dec 2023
$184.79M(+47.6%)
$184.79M(+47.6%)
Dec 2022
$125.18M(+211.0%)
-
Dec 2022
-
$125.18M
Dec 2021
$40.25M
-

FAQ

  • What is CG Oncology, Inc. annual stockholders equity?
  • What is the all time high annual shareholders equity for CG Oncology, Inc.?
  • What is CG Oncology, Inc. annual shareholders equity year-on-year change?
  • What is CG Oncology, Inc. quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for CG Oncology, Inc.?
  • What is CG Oncology, Inc. quarterly shareholders equity year-on-year change?

What is CG Oncology, Inc. annual stockholders equity?

The current annual shareholders equity of CGON is $733.38M

What is the all time high annual shareholders equity for CG Oncology, Inc.?

CG Oncology, Inc. all-time high annual stockholders equity is $733.38M

What is CG Oncology, Inc. annual shareholders equity year-on-year change?

Over the past year, CGON annual stockholders equity has changed by +$548.59M (+296.87%)

What is CG Oncology, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of CGON is $670.36M

What is the all time high quarterly shareholders equity for CG Oncology, Inc.?

CG Oncology, Inc. all-time high quarterly stockholders equity is $733.38M

What is CG Oncology, Inc. quarterly shareholders equity year-on-year change?

Over the past year, CGON quarterly stockholders equity has changed by +$118.00M (+21.36%)
On this page